Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism-Reference-Cited by-同舟云学术

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism

Published:2019-06-30 Issue:2 Volume:38 Page:229-238
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract.

Author:

Pérez-Ricart Ariadna¹^ORCID,Galicia-Basart Maria²^ORCID,Comas-Sugrañes Dolors³,Cruzado-Garrit Josep-Maria⁴,Segarra-Medrano Alfons⁵^ORCID,Montoro-Ronsano José-Bruno¹^ORCID

Affiliation:

1. Pharmacy Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain

2. Nephrology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain

3. Pharmacy Department. Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain

4. Nephrology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain

5. Nephrology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain

Funder

Col·legi Oficial de Farmacèutics de Barcelona

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://pdf.medrang.co.kr/KRCP2/2019/038/KRCP038-02-229.pdf

Reference32 articles.

1. Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options

2. Foreword

3. Bone metabolism and disease in chronic kidney disease

4. Amgen Inc SENSIPAR® (cinacalcet) [Internet]. Silver Spring (US): Food and Drug Administration, 2014 [cited 2016 May date]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021688s20_21_22lbl.pdf.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism;Nephrology Dialysis Transplantation;2021-12-09

2. Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency;Expert Opinion on Drug Safety;2021-06-09

3. Thick ascending limb claudins are altered to increase calciuria and magnesiuria in metabolic acidosis;American Journal of Physiology-Renal Physiology;2021-03-01

4. Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication;Korean Circulation Journal;2021

5. Treatment of Hyperparathyroidism (SHPT);Brazilian Journal of Nephrology;2021